RELATED CONTENT
At RSNA 2012, InSightec Ltd. announced U.S. Food and Drug Administration (FDA) approval for the ExAblate magnetic resonance imaging (MRI) guided focused ultrasound for treatment of painful bone metastases in patients who are not candidates for or refuse to undergo radiation treatment.
December 19, 2012 
August 24, 2012 — On August 20, 2012, InSightec announced it received approval from the U.S. Food and Drug Administration (FDA) to begin Phase I clinical trials evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor-dominant Parkinson’s Disease (PD). This device is the first clinical system to use magnetic resonance- (MR) guided focused ultrasound (MRgFUS) through an intact skull, offering noninvasive transcranial treatment without any incisions or ionizing radiation.
August 24, 2012 January 25, 2012 — InSightec Ltd. announced that it has submitted a premarket approval application (PMA) to the U.S. Food and Drug Administration (FDA) for its ExAblate treatment of pain palliation of bone metastases.
January 25, 2012 November 11, 2009 - Non-invasive treatment with the ExAblate Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system by InSightec Ltd. reduces risk in treating symptomatic uterine fibroids, according to a study published in the November issue of Ultrasound in Obstetrics and Gynecology.
November 11, 2009 
More women are learning about an imaging technique that offers a noninvasive alternative to hysterectomy for women with uterine fibroids and they are finding this procedure to be very accessible in outpatient centers.
October 01, 2008 May 28, 2008 - InSightec Ltd. announced today that the FDA cleared the company to conduct a clinical trial to evaluate ...
May 27, 2008 December 19, 2007 - InSightec Ltd. announced that the FDA has approved an investigational device exemptions (IDE) ...
December 18, 2007 June 6, 2007 - InSightec Ltd. announced that it has received CE Mark certification for its ExAblate 2000, a system that ...
June 05, 2007 February 21, 2007 – InSightec’s ExAblate 2000, a Magnetic Resonance Imaging (MRI) focused ultrasound device that treats ...
February 20, 2007